July 3, 2023

Sue Peschin – FDA, CMS, and Alzheimer’s Drugs: What Do American Voters Want?

Sue Peschin – FDA, CMS, and Alzheimer’s Drugs: What Do American Voters Want?

About This Episode

Should Alzheimer’s drugs be treated like all other drugs when it comes to Medicare coverage? The Alliance for Aging Research CEO Sue Peschin and BrainStorm host Meryl Comer dive into polling data that reveals most American voters, regardless of party, disagree with CMS’s policy that will limit access. Their conversation sheds light on how the coverage decision, if it stands, will create not only greater disparities, but also have wide-ranging implications on coverage for other disease-modifying therapies. 

This episode is sponsored by Eisai.

Support the show

BrainStorm Feed

48

The Alzheimer’s Journey – Stories from Those Who Live the Disease

There is nothing more powerful than the stories of people who are directly affected by Alzheimer’s.

LISTEN NOW
47

Susan Magsamen, MAS, Co-author of Your Brain on Art, How the Arts Transform Us (part 2)

What do technology, AI and the Arts have in common?

LISTEN NOW
46

Susan Magsamen, MAS, Co-author of Your Brain on Art, How the Arts Transform Us (part 1)

Art for Art's sake is about to become passe with the emerging science of neuroaesthetics, an expanding field of research aimed at the intersection

LISTEN NOW